Lead Product(s) : Deuterium Oxide
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 14, 2013
Lead Product(s) : Deuterium Oxide
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Deuterium Oxide
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : Pharmacyclics
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 19, 2012
Lead Product(s) : Deuterium Oxide
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : Pharmacyclics
Deal Size : Inapplicable
Deal Type : Inapplicable